Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.
Patients with COPD are often reluctant to talk about the negative impact of the disease on their lives. But these unspoken concerns may become barriers to effective management. It is up to you to ask the appropriate, often difficult questions. Here, 5 examples of things your patients with COPD might not be telling you—and why you need to know.